Martignetti A - Search Results

1

Ultra-low-dose interleukin-2 in unresectable hepatocellular carcinoma.

Palmieri G, Montella L, Milo M, Fiore R, Biondi E, Bianco AR, Martignetti A. Palmieri G, et al. Among authors: martignetti a. Am J Clin Oncol. 2002 Jun;25(3):224-6. doi: 10.1097/00000421-200206000-00003. Am J Clin Oncol. 2002. PMID: 12040276 Clinical Trial.

2

Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects.

Tagliaferri P, Barile C, Caraglia M, Guarrasi R, Morelli D, Ricciardi B, Martignetti A, Librera MT, Matano E, Della Vecchia A, Catalano G, Famiani M, Palmieri G, Correale P, Bianco AR. Tagliaferri P, et al. Among authors: martignetti a. Am J Clin Oncol. 1998 Feb;21(1):48-53. doi: 10.1097/00000421-199802000-00011. Am J Clin Oncol. 1998. PMID: 9499257 Clinical Trial.

3

The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer.

De Placido S, Lauria R, Carlomagno C, Perrone F, De Laurentiis M, Gallo C, Martignetti A, Bellelli T, Limite G, Petrella G, Bianco AR. De Placido S, et al. Among authors: martignetti a. Int J Oncol. 1999 Aug;15(2):339-46. Int J Oncol. 1999. PMID: 10402245 Clinical Trial.

4

Role of surgery in thymic disorders.

Persico G, Martignetti A, Imbriani A, Montella L, Aprea G, Coto M, Persico F, Palmieri G. Persico G, et al. Among authors: martignetti a. Ann Med. 1999 Oct;31 Suppl 2:70-2. Ann Med. 1999. PMID: 10574159 Review.

5

Role of somatostatin analogue-based therapy in unresponsive malignant thymomas.

Palmieri G, Lastoria S, Montella L, Martignetti A, Lombardi G, Salvatore M, Bianco AR. Palmieri G, et al. Among authors: martignetti a. Ann Med. 1999 Oct;31 Suppl 2:80-5. Ann Med. 1999. PMID: 10574161

6

Immunological findings in thymoma and thymoma-related syndromes.

Masci AM, Palmieri G, Perna F, Montella L, Merkabaoui G, Sacerdoti G, Martignetti A, Racioppi L. Masci AM, et al. Among authors: martignetti a. Ann Med. 1999 Oct;31 Suppl 2:86-9. Ann Med. 1999. PMID: 10574162

7

Interferon alpha-2b at low doses as long-term antiangiogenic treatment of a metastatic intracranial hemangioendothelioma: a case report.

Palmieri G, Montella L, Martignetti A, Bianco AR. Palmieri G, et al. Among authors: martignetti a. Oncol Rep. 2000 Jan-Feb;7(1):145-9. Oncol Rep. 2000. PMID: 10601609 Review.

8

Somatostatin analogs and prednisone in advanced refractory thymic tumors.

Palmieri G, Montella L, Martignetti A, Muto P, Di Vizio D, De Chiara A, Lastoria S. Palmieri G, et al. Among authors: martignetti a. Cancer. 2002 Mar 1;94(5):1414-20. doi: 10.1002/cncr.10374. Cancer. 2002. PMID: 11920496 Free article. Clinical Trial.

9

Low-dose recombinant IL-2 induces psychological changes: monitoring by Minnesota Multiphasic Personality Inventory (MMPI).

Pizzi C, Caraglia M, Cianciulli M, Fabbrocini A, Libroia A, Matano E, Contegiacomo A, Del Prete S, Abbruzzese A, Martignetti A, Tagliaferri P, Bianco AR. Pizzi C, et al. Among authors: martignetti a. Anticancer Res. 2002 Mar-Apr;22(2A):727-32. Anticancer Res. 2002. PMID: 12014643 Clinical Trial.

10

Prognostic-significance of multifocality in primary breast-cancer.

Morabito A, Perrone F, Lauria R, Carlomagno C, Marinelli A, Delaurentiis M, Martignetti A, Pettinato G, Panico L, Petrella G, Gallo C, Bianco A, Deplacido S. Morabito A, et al. Among authors: martignetti a. Oncol Rep. 1994 Nov;1(6):1045-8. doi: 10.3892/or.1.6.1045. Oncol Rep. 1994. PMID: 21607488

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page